Sydney Cardiovascular Fellowships 2018
Charles Perkins Centre and the Heart Research Institute
- The most prestigious fellowships in Australia for outstanding and independent early and mid-career cardiovascular researchers
- Join the largest consortium of cardiovascular researchers in Australia
- 5 year fixed term contract with attractive remuneration
About the opportunity
The Heart Research Institute (HRI) and the Charles Perkins Centre of the University of Sydney are seeking exceptional national and international early to mid-career researchers with the potential to become global leaders in cardiovascular research for the Sydney Cardiovascular Fellowships 2018.
We are targeting outstanding early to mid-career independent research leaders with a package including research support valued at $1,000,000 over five years, or truly exceptional mid-career or later research leaders, for whom we will negotiate an appropriately attractive package including research support (up to $2,000,000 over 5 years). These opportunities represent the most prestigious fellowships in Australia for early and mid-career cardiovascular researchers.
The HRI, in partnership with the Charles Perkins Centre, University of Sydney, Royal Prince Alfred Hospital, and affiliated Medical Research Institutes represent the largest consortium of cardiovascular researchers in Australia. The $500 million investment in the Charles Perkins Centre by the University of Sydney represents one of the largest single investments in diabetes, obesity, and CV research globally.
We value courage and creativity; openness and engagement; inclusion and diversity; and respect and integrity. As such, we see the importance of recruiting talent aligned to these values and are looking for successful applicants who will interact closely with the following research expertise already present at the HRI and Charles Perkins Centre research consortium:
- Atherosclerosis and its complications
- Vascular biology and thromboembolic disease
- Cardiometabolic disease
- Cardiovascular tissue engineering and biomaterials
- Cardiovascular genetics and sudden cardiac death
- Thromboembolic diseases in diabetes and cancer
- Medicinal Chemistry / Chemical Biology
Applicants performing research in these or complementary areas will be considered.
The Sydney Cardiovascular Research Consortium (Sydney CRC) is a partnership between Heart Research Institute (HRI), The University of Sydney (USYD), Charles Perkins Centre (CPC), Royal Prince Alfred Hospital (RPA), Sydney Local Health District (SLHD), and affiliated medical research institutes such as the Centenary Institute and The George Institute for Global Health. This consortium brings together enormous resources and expertise in a unified and focused collaboration.
Since our inception 160 years ago, the University of Sydney has led to improve the world around us. We believe in education for all and that effective leadership makes lives better. These same values are reflected in our approach to diversity and inclusion, and underpin our long-term strategy for growth. We’re Australia's first university and have an outstanding global reputation for academic and research excellence. Across our campuses, we employ over 7600 academic and non-academic staff who support over 60,000 students.
We are undergoing significant transformative change which brings opportunity for innovation, progressive thinking, breaking with convention, challenging the status quo, and improving the world around us.
How to apply
For more information on the position and to find out about the application process visit sydney.edu.au/recruitment and search by the reference number.
Closing date: 11:30 pm, 31 March 2018 (Sydney time)
The University of Sydney is committed to diversity and social inclusion. Applications from people of culturally and linguistically diverse backgrounds; equity target groups including women, people with disabilities, people who identify as LGBTIQ; and people of Aboriginal and Torres Strait Islander descent, are encouraged.
© The University of Sydney
The University reserves the right not to proceed with any appointment.